Companies within the life sciences industries are continually experiencing an increased need for specialist know-how regarding the statutory regimes which is particularly important for this sector. Irrespective of whether the entity is a start-up research or development company within the biotech industry or a multinational pharmaceuticals group, commercial success often depends on having legal control over one's own intellectual property assets and taking legal action when these assets are threatened as a consequence, e.g., of unlawful parallel imports, or patent infringement.
Closely associated with this is the need to have carefully thought-out agreements with employees. Within, e.g., the biotech area and the pharmaceutical industry, structural corporate acquisitions and financing are becoming increasingly frequent. In connection with these transactions, it is necessary to be assisted by lawyers who, as a result of their experience of transactions and familiarity with the industry's commercial conditions, are able to carry out a transaction promptly and efficiently, maintaining the highest possible standards.
Corporate acquisitions within these industries are also often affected by the fact that the target company does not have any products but instead is engaged in research projects which will lead to products in the future. This means that specially structured agreements are required. Specialist expertise regarding the permits required for each industry is also important.